The STUDIA UNIVERSITATIS BABEŞ-BOLYAI issue article summary

The summary of the selected article appears at the bottom of the page. In order to get back to the contents of the issue this article belongs to you have to access the link from the title. In order to see all the articles of the archive which have as author/co-author one of the authors mentioned below, you have to access the link from the author's name.

  
       
         
    STUDIA CHEMIA - Issue no. 2, Tom II / 2019  
         
  Article:   PHARMACOKINETIC PROOFS ON INTERACTION BETWEEN ZOLPIDEM AND PHENYTOIN: A TWO-TREATMENT, TWO-PERIOD STUDY IN HEALTHY MALE SUBJECTS.

Authors:  DANA MARIA MUNTEAN, MARIA ADRIANA NEAG, DANIELA PETRUTA PRIMEJDIE, ADINA POPA, MARCELA ACHIM, LAURIAN VLASE. 		 
       
         
  Abstract:  In clinical practice, the simultaneous use of zolpidem and phenytoin cannot always be avoided, although it can be associated with additive depressants effects on the central nervous system. Considering the common metabolic pathways involving CYP3A and CYP2C, a pharmacokinetic interaction between phenytoin and zolpidem is possible, although not previously quantified. The study was designed as a non-randomized, two-period preclinical trial. Twenty male subjects were included in a study consisting of two periods. Between these, subjects were treated for 6 days with a single daily dose of 150 mg phenytoin. For each treatment period, pharmacokinetic parameters of zolpidem were determined. The multiple-dose administration of phenytoin influenced zolpidem’s pharmacokinetics in healthy volunteers, decreasing its exposure through enzymatic induction.

Keywords: zolpidem; phenytoin; drug interaction; enzymatic induction 		 
         
     
         
         
      Back to previous page